Open Call#2 for Accelerating Data-Driven Solutions to Save Lives from COVID-19

The consortium of COVID-X announces the launch of Open Call #2 for a unique acceleration programme in Europe to fast-track to market 15+ European data technology solutions, addressing COVID-19 challenges and facilitating an innovative stack of AI-driven tools in order to defeat the pandemic.

COVID-X Programme, supported by the European Commission under Horizon2020 programme, funds European companies and healthcare providers to boost 30+ data-driven solutions to the markets to overcome clinical challenges in diagnosis, prognosis, and follow-up. The funding is invested in solutions with TRL 7+ and [or in the process of] CE marking, covering two profiles: single solution (EU tech SMEs / Start-Ups) validating their solutions at one of COVID-X pilot sites; or team solution (Tech provider bringing in a healthcare provider that will validate the solution).

In addition to the direct funding, the COVID-X Programme provides the top-ranked solutions access in a tailored acceleration programme organized in 3 sprints of 3 months each. These include technical coaching, business mentoring sessions as well as support in ethical issues and piloting with healthcare organizations. This 10-month programme targets to boost the quick market uptake to defeat COVID-19 with data solutions.

To attract top-notch solutions meeting the set selection criteria, the Open Call#2 has a two-stage application process: In the first stage, the applicant's eligibility and alignment with the selection criteria are assessed. All eligible applications access the 2nd stage where the complete application form with detailed information about the solution & implementation is required.

The COVID-X Programme Open Call #1 closed on 27.1.2021 gathering 112 applications from data technology companies and healthcare providers coming from 29 different countries in Europe and beyond. 16 selected single and team solutions were selected and are now completing the 1st Sprint of the programme.

The Open Call#2 application is now open and the deadline for the first stage will be on the 22nd of July 2021. (17:00PM CEST).

For further infromation, please visit:
https://www.covid-x.eu/apply-now/

Most Popular Now

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...